TY  - CONF
AU  - Tadić, Ivana
AU  - van Boven, Job
AU  - Tsiligianni, Ioanna
AU  - Potočnjak, Ines
AU  - Mihajlović, Jovan
AU  - Dima, Alexandra Lelia
AU  - Nabergoj Makovec, Urška
AU  - Ágh, Tamás
AU  - Kardas, Przemyslaw
AU  - Ghiciuc, Cristina Mihaela
AU  - Petrova, Guenka
AU  - Bitterman, Noemi
AU  - Kamberi, Fatjona
AU  - Culig, Josip
AU  - Wettermark, Bjorn
AU  - Marinković, Valentina
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4494
AB  - Medication non-adherence is recognized as a global problem associated with financial burden for patients
and healthcare funds. At the European level, different Medication Adherence Technologies (MATech) are in use. The
European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action
19132) was launched to: 1) identify current practices for Medication Adherence (MA) support by healthcare
professionals; 2) create a structure for the repository of existing MATech that could be used by different
stakeholders; and to 3) prepare guidance for sustainable implementation of MATech across European healthcare
settings. ENABLE gathered different healthcare professionals and academics from 39 countries, to achieve the set of
goals during a four-year period. Several cross-European studies were conducted employing stakeholder
consultation (Delphi) and survey methods, including analysis of current practices for assessing and supporting MA
in routine care, as well as barriers and facilitators to managing MA, work on medication management during COVID
pandemic, reimbursement pathways of adherence interventions and protocols to identify the best practices and
technologies. The MATech repository was designed by ENABLE members, and consultation of different stakeholders
is currently in progress. The repository structure includes information about the MATech product and provider,
goals and content related to managing MA, and information about the scientific evaluation and implementation. A
cross-European expert survey identified a limited number of MA enhancing interventions that are currently subject
to reimbursement. ENABLE identified the need for collaboration, infrastructure, and reimbursement to enhance the
uptake of MATech in daily practice.
AB  - Neadherenca pacijenata prema terapiji prepoznata je kao globalni problem udružen sa finansijskim
opterećenjem pojedinaca i zdravstvenih sistema. Na nivou Evrope koriste se različite tehnologije za unapređenje
adherence (Medication Adherence Technologies - MATech). Evropska mreža za razvoj najboljih praksi i tehnologija
za unapređenje adherence (ENABLE, COST Action 19132) pokrenuta je sa ciljem da se: 1) identifikuju trenutne
prakse unapređenja adherence (medication adhrerence – MA) od strane zdravstvenih profesionalaca; 2) kreira
struktura repozitorijuma postojećih MATech koju mogu da koriste različiti stejkholderi; 3) da se pripreme vodiči za
održivu implementaciju MATech širom Evrope. ENABLE okuplja zdravstvene profesionalce različitih profesija iz 39
zemalja kako bi se postigli ciljevi tokom četvorogodišnjeg perioda. Nekoliko studija u više zemalja Evrope pokrenuto
je kako bi se izvršilo ispitivanje 1) stavova različitih stejkholdera delfi metodom i upitnicima, uključujući analizu
trenutnih praksi u vezi analize i podrške MA u rutinskoj praksi, kao i barijere i facilitatore koji utiču na MA, 2)
menadžment lekovima tokom COVID pandemije, 3) načine refundacije intervencija u vezi sa MA i 4) protokola koji
identifikuju nabolje prakse i tehnologije. Kreirana je struktura MATech repozitorijuma, dok je usaglašavanje sa
različitim stejkholderima u toku. Struktura repozitorijuma zasniva se na informacijama o MATech, ciljevima i
sadržajima u vezi MA, i informacijama o naučnim procenama i implementaciji MATech. Na području Evrope
istraživanje je identifikovalo ograničeni broj intervencija za unapređenje MA koje podležu refundaciji. ENABLE
ukazuje na potrebu za kolaboracijom, razvojem infrastrukture i politike refundacije kako bi se unapredila upotreba
MATech u rutinskoj praksi.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Advancement of practice and use of medication adherence technologies
T1  - Unapređenje prakse i upotrebe tehnologija za unapređenje adherence
VL  - 72
IS  - 4 suplement
SP  - S202
EP  - S203
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4494
ER  - 

@conference{
author = "Tadić, Ivana and van Boven, Job and Tsiligianni, Ioanna and Potočnjak, Ines and Mihajlović, Jovan and Dima, Alexandra Lelia and Nabergoj Makovec, Urška and Ágh, Tamás and Kardas, Przemyslaw and Ghiciuc, Cristina Mihaela and Petrova, Guenka and Bitterman, Noemi and Kamberi, Fatjona and Culig, Josip and Wettermark, Bjorn and Marinković, Valentina",
year = "2022",
abstract = "Medication non-adherence is recognized as a global problem associated with financial burden for patients
and healthcare funds. At the European level, different Medication Adherence Technologies (MATech) are in use. The
European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action
19132) was launched to: 1) identify current practices for Medication Adherence (MA) support by healthcare
professionals; 2) create a structure for the repository of existing MATech that could be used by different
stakeholders; and to 3) prepare guidance for sustainable implementation of MATech across European healthcare
settings. ENABLE gathered different healthcare professionals and academics from 39 countries, to achieve the set of
goals during a four-year period. Several cross-European studies were conducted employing stakeholder
consultation (Delphi) and survey methods, including analysis of current practices for assessing and supporting MA
in routine care, as well as barriers and facilitators to managing MA, work on medication management during COVID
pandemic, reimbursement pathways of adherence interventions and protocols to identify the best practices and
technologies. The MATech repository was designed by ENABLE members, and consultation of different stakeholders
is currently in progress. The repository structure includes information about the MATech product and provider,
goals and content related to managing MA, and information about the scientific evaluation and implementation. A
cross-European expert survey identified a limited number of MA enhancing interventions that are currently subject
to reimbursement. ENABLE identified the need for collaboration, infrastructure, and reimbursement to enhance the
uptake of MATech in daily practice., Neadherenca pacijenata prema terapiji prepoznata je kao globalni problem udružen sa finansijskim
opterećenjem pojedinaca i zdravstvenih sistema. Na nivou Evrope koriste se različite tehnologije za unapređenje
adherence (Medication Adherence Technologies - MATech). Evropska mreža za razvoj najboljih praksi i tehnologija
za unapređenje adherence (ENABLE, COST Action 19132) pokrenuta je sa ciljem da se: 1) identifikuju trenutne
prakse unapređenja adherence (medication adhrerence – MA) od strane zdravstvenih profesionalaca; 2) kreira
struktura repozitorijuma postojećih MATech koju mogu da koriste različiti stejkholderi; 3) da se pripreme vodiči za
održivu implementaciju MATech širom Evrope. ENABLE okuplja zdravstvene profesionalce različitih profesija iz 39
zemalja kako bi se postigli ciljevi tokom četvorogodišnjeg perioda. Nekoliko studija u više zemalja Evrope pokrenuto
je kako bi se izvršilo ispitivanje 1) stavova različitih stejkholdera delfi metodom i upitnicima, uključujući analizu
trenutnih praksi u vezi analize i podrške MA u rutinskoj praksi, kao i barijere i facilitatore koji utiču na MA, 2)
menadžment lekovima tokom COVID pandemije, 3) načine refundacije intervencija u vezi sa MA i 4) protokola koji
identifikuju nabolje prakse i tehnologije. Kreirana je struktura MATech repozitorijuma, dok je usaglašavanje sa
različitim stejkholderima u toku. Struktura repozitorijuma zasniva se na informacijama o MATech, ciljevima i
sadržajima u vezi MA, i informacijama o naučnim procenama i implementaciji MATech. Na području Evrope
istraživanje je identifikovalo ograničeni broj intervencija za unapređenje MA koje podležu refundaciji. ENABLE
ukazuje na potrebu za kolaboracijom, razvojem infrastrukture i politike refundacije kako bi se unapredila upotreba
MATech u rutinskoj praksi.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Advancement of practice and use of medication adherence technologies, Unapređenje prakse i upotrebe tehnologija za unapređenje adherence",
volume = "72",
number = "4 suplement",
pages = "S202-S203",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4494"
}

Tadić, I., van Boven, J., Tsiligianni, I., Potočnjak, I., Mihajlović, J., Dima, A. L., Nabergoj Makovec, U., Ágh, T., Kardas, P., Ghiciuc, C. M., Petrova, G., Bitterman, N., Kamberi, F., Culig, J., Wettermark, B.,& Marinković, V.. (2022). Advancement of practice and use of medication adherence technologies. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S202-S203.
https://hdl.handle.net/21.15107/rcub_farfar_4494

Tadić I, van Boven J, Tsiligianni I, Potočnjak I, Mihajlović J, Dima AL, Nabergoj Makovec U, Ágh T, Kardas P, Ghiciuc CM, Petrova G, Bitterman N, Kamberi F, Culig J, Wettermark B, Marinković V. Advancement of practice and use of medication adherence technologies. in Arhiv za farmaciju. 2022;72(4 suplement):S202-S203.
https://hdl.handle.net/21.15107/rcub_farfar_4494 .

Tadić, Ivana, van Boven, Job, Tsiligianni, Ioanna, Potočnjak, Ines, Mihajlović, Jovan, Dima, Alexandra Lelia, Nabergoj Makovec, Urška, Ágh, Tamás, Kardas, Przemyslaw, Ghiciuc, Cristina Mihaela, Petrova, Guenka, Bitterman, Noemi, Kamberi, Fatjona, Culig, Josip, Wettermark, Bjorn, Marinković, Valentina, "Advancement of practice and use of medication adherence technologies" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S202-S203,
https://hdl.handle.net/21.15107/rcub_farfar_4494 .

TY  - JOUR
AU  - Robinson, Emma Louise
AU  - da Costa Gomes, Clarissa Pedrosa
AU  - Potočnjak, Ines
AU  - Hellemans, Jan
AU  - Betsou, Fay
AU  - de Gonzalo-Calvo, D.
AU  - Stoll, M.
AU  - Yilmaz, M.B.
AU  - Ágg, B.
AU  - Beis, D.
AU  - Carmo-Fonseca, M.
AU  - Enguita, F.J.
AU  - Dogan, S.
AU  - Tuna, B.G.
AU  - Schroen, B.
AU  - Ammerlaan, W.
AU  - Kuster, G.M.
AU  - Carpusca, I.
AU  - Pedrazzini, T.
AU  - Emanueli, C.
AU  - Martelli, F.
AU  - Devaux, Y.
AU  - Acharya, S.
AU  - Aghagolzadeh, P.
AU  - Albinsson, S.
AU  - Allaer, D.
AU  - Andova, A.
AU  - Angione, C.
AU  - Arnal, J.-F.
AU  - Arslan, S.
AU  - Lustrek, M.
AU  - Maegdefessel, L.
AU  - Marchese, M.
AU  - Martino, F.
AU  - Mazzanti, C.
AU  - Meli, A.
AU  - Tonczar, J.M.
AU  - Murri, M.
AU  - Niculescu, L.S.
AU  - Backs, J.
AU  - Nielsen, N.
AU  - Nossent, A.Y.
AU  - Novella, S.
AU  - Novokmet, N.
AU  - O'brien, T.
AU  - Oliveira, C.
AU  - Orbe, J.
AU  - Paes, A.
AU  - Papaneophytou, C.
AU  - Badimon, L.
AU  - Perez-Pomares, J.
AU  - Pinet, F.
AU  - Popescu, O.
AU  - Potocnjak, I.
AU  - Rizanov, A.
AU  - Ruberto, F.
AU  - Pipaon, G.S.
AU  - Sahoo, S.
AU  - Baker, A.
AU  - Somoza, A.S.
AU  - Sanchez-Madrid, F.
AU  - Sasson, S.
AU  - Scholz, M.
AU  - Semenovykh, D.
AU  - Simionescu, M.
AU  - Soar, A.
AU  - Sopić, Miron
AU  - Sorensen, A.
AU  - Barbalata, T.
AU  - Spinetti, G.
AU  - Squire, I.
AU  - Srivastava, P.
AU  - Stancu, C.S.
AU  - Benic, M.S.
AU  - Stefanizzi, F.M.
AU  - Steffens, S.
AU  - Stellos, K.
AU  - Thum, T.
AU  - Barbosa, P.
AU  - Tikhomirov, R.
AU  - Toledo, M.
AU  - Trbusic, M.
AU  - Chalot, S.
AU  - Turkieh, A.
AU  - Van Der Bent, M.L.
AU  - Ingen, E.V.
AU  - Rooij, E.V.
AU  - Vanhaverbeke, M.
AU  - Varga, Z.
AU  - Bartekova, M.
AU  - Verjans, R.
AU  - Vilahur, G.
AU  - Vinciguerra, M.
AU  - Vindis, C.
AU  - Wac, K.
AU  - Whittaker, A.
AU  - Xuereb, A.
AU  - Zangi, L.
AU  - Zhang, L.
AU  - Bashiardes, E.
AU  - Stathopoulos, C.
AU  - Ciccarelli, M.
AU  - Serobian, A.
AU  - Gevorgyan, S.
AU  - Bencsik, P.
AU  - Wettinger, S.B.
AU  - Brandenburger, T.
AU  - Brittan, M.
AU  - Bugarski, B.
AU  - Demur, A.B.
AU  - Catapano, F.
AU  - Charchar, F.
AU  - Charrier, H.
AU  - Chimenti, S.
AU  - Chouvardas, P.
AU  - Closa, D.
AU  - Colotte, M.
AU  - Condorelli, G.
AU  - Curado, J.
AU  - Dafou, D.
AU  - Dalgaard, L.T.
AU  - Calvo, D.G.
AU  - Windt, L.D.
AU  - Degoricija, V.
AU  - Dellago, H.
AU  - Dieterich, C.
AU  - Djordjevic, V.
AU  - Dlaka, A.
AU  - Doehner, W.
AU  - Farrugia, R.
AU  - Fazmin, I.
AU  - Felekkis, K.
AU  - Ferdinandylino Ferreira, P.
AU  - Fiedorowicz, K.
AU  - Foo, R.
AU  - Formosa, M.
AU  - Forte, G.
AU  - Gaetano, C.
AU  - Garcia Bermejo, M.L.
AU  - Garcia-Sosa, A.
AU  - Gonzalez-Navarro, H.
AU  - Greco, S.
AU  - Gulyas-Onodi, Z.
AU  - Gyongyosi, M.
AU  - Hackl, M.
AU  - Hein, L.
AU  - Heineke, J.
AU  - Heymans, S.
AU  - Hlavackova, M.
AU  - Hoydal, M.A.
AU  - Jankovic, A.
AU  - Jeevaratnam, K.
AU  - Johnson, R.
AU  - Jusic, A.
AU  - Justo Da Silva, G.
AU  - Kalocayova, B.
AU  - Hadziabdic, K.K.
AU  - Kardassis, D.
AU  - Kastner, N.
AU  - Keravnou, A.
AU  - Kerkela, R.
AU  - Kofanova, O.
AU  - Korac, A.
AU  - Kura, B.
AU  - Kuster, G.
AU  - Lacampagne, A.
AU  - Lakkisto, P.
AU  - Robbio, L.L.
AU  - Lazou, A.
AU  - Leszek, P.
AU  - Li, Z.
AU  - Liapi, E.
AU  - Lino, M.
AU  - Luis, R.
AU  - Gehmlich, K.
AU  - Dedoussis, G.
AU  - Makimoto, H.
AU  - da Costa Martins, P.
AU  - Sanchez, G.
AU  - Firat, H.
AU  - Katare, R.
AU  - Edling, C.
AU  - Pesce, M.
AU  - Capogrossi, M.C.
AU  - Beltrami, A.P.
PY  - 2020
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086089216&doi=10.3390%2fNCRNA6020017&partnerID=40&md5=28b18f4c01dd8f05e8a1704cefbbe268
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5032
AB  - The EU-CardioRNA Cooperation in Science and Technology (COST) Action is a European-wide consortium established in 2018 with 31 European country members and four associate member countries to build bridges between translational researchers from academia and industry who conduct research on non-coding RNAs, cardiovascular diseases and similar research areas. EU-CardioRNA comprises four core working groups (WG1-4). In the first year since its launch, EU-CardioRNA met biannually to exchange and discuss recent findings in related fields of scientific research, with scientific sessions broadly divided up according to WG. These meetings are also an opportunity to establish interdisciplinary discussion groups, brainstorm ideas and make plans to apply for joint research grants and conduct other scientific activities, including knowledge transfer. Following its launch in Brussels in 2018, three WG meetings have taken place. The first of these in Lisbon, Portugal, the second in Istanbul, Turkey, and the most recent in Maastricht, The Netherlands. Each meeting includes a scientific session from each WG. This meeting report briefly describes the highlights and key take-home messages from each WG session in this first successful year of the EU-CardioRNA COST Action.
PB  - MDPI AG
T2  - Non-coding RNA
T1  - A year in the life of the EU-CardioRNA COST action: CA17129 catalysing transcriptomics research in cardiovascular disease
VL  - 6
IS  - 2
DO  - 10.3390/NCRNA6020017
ER  - 

@article{
author = "Robinson, Emma Louise and da Costa Gomes, Clarissa Pedrosa and Potočnjak, Ines and Hellemans, Jan and Betsou, Fay and de Gonzalo-Calvo, D. and Stoll, M. and Yilmaz, M.B. and Ágg, B. and Beis, D. and Carmo-Fonseca, M. and Enguita, F.J. and Dogan, S. and Tuna, B.G. and Schroen, B. and Ammerlaan, W. and Kuster, G.M. and Carpusca, I. and Pedrazzini, T. and Emanueli, C. and Martelli, F. and Devaux, Y. and Acharya, S. and Aghagolzadeh, P. and Albinsson, S. and Allaer, D. and Andova, A. and Angione, C. and Arnal, J.-F. and Arslan, S. and Lustrek, M. and Maegdefessel, L. and Marchese, M. and Martino, F. and Mazzanti, C. and Meli, A. and Tonczar, J.M. and Murri, M. and Niculescu, L.S. and Backs, J. and Nielsen, N. and Nossent, A.Y. and Novella, S. and Novokmet, N. and O'brien, T. and Oliveira, C. and Orbe, J. and Paes, A. and Papaneophytou, C. and Badimon, L. and Perez-Pomares, J. and Pinet, F. and Popescu, O. and Potocnjak, I. and Rizanov, A. and Ruberto, F. and Pipaon, G.S. and Sahoo, S. and Baker, A. and Somoza, A.S. and Sanchez-Madrid, F. and Sasson, S. and Scholz, M. and Semenovykh, D. and Simionescu, M. and Soar, A. and Sopić, Miron and Sorensen, A. and Barbalata, T. and Spinetti, G. and Squire, I. and Srivastava, P. and Stancu, C.S. and Benic, M.S. and Stefanizzi, F.M. and Steffens, S. and Stellos, K. and Thum, T. and Barbosa, P. and Tikhomirov, R. and Toledo, M. and Trbusic, M. and Chalot, S. and Turkieh, A. and Van Der Bent, M.L. and Ingen, E.V. and Rooij, E.V. and Vanhaverbeke, M. and Varga, Z. and Bartekova, M. and Verjans, R. and Vilahur, G. and Vinciguerra, M. and Vindis, C. and Wac, K. and Whittaker, A. and Xuereb, A. and Zangi, L. and Zhang, L. and Bashiardes, E. and Stathopoulos, C. and Ciccarelli, M. and Serobian, A. and Gevorgyan, S. and Bencsik, P. and Wettinger, S.B. and Brandenburger, T. and Brittan, M. and Bugarski, B. and Demur, A.B. and Catapano, F. and Charchar, F. and Charrier, H. and Chimenti, S. and Chouvardas, P. and Closa, D. and Colotte, M. and Condorelli, G. and Curado, J. and Dafou, D. and Dalgaard, L.T. and Calvo, D.G. and Windt, L.D. and Degoricija, V. and Dellago, H. and Dieterich, C. and Djordjevic, V. and Dlaka, A. and Doehner, W. and Farrugia, R. and Fazmin, I. and Felekkis, K. and Ferdinandylino Ferreira, P. and Fiedorowicz, K. and Foo, R. and Formosa, M. and Forte, G. and Gaetano, C. and Garcia Bermejo, M.L. and Garcia-Sosa, A. and Gonzalez-Navarro, H. and Greco, S. and Gulyas-Onodi, Z. and Gyongyosi, M. and Hackl, M. and Hein, L. and Heineke, J. and Heymans, S. and Hlavackova, M. and Hoydal, M.A. and Jankovic, A. and Jeevaratnam, K. and Johnson, R. and Jusic, A. and Justo Da Silva, G. and Kalocayova, B. and Hadziabdic, K.K. and Kardassis, D. and Kastner, N. and Keravnou, A. and Kerkela, R. and Kofanova, O. and Korac, A. and Kura, B. and Kuster, G. and Lacampagne, A. and Lakkisto, P. and Robbio, L.L. and Lazou, A. and Leszek, P. and Li, Z. and Liapi, E. and Lino, M. and Luis, R. and Gehmlich, K. and Dedoussis, G. and Makimoto, H. and da Costa Martins, P. and Sanchez, G. and Firat, H. and Katare, R. and Edling, C. and Pesce, M. and Capogrossi, M.C. and Beltrami, A.P.",
year = "2020",
abstract = "The EU-CardioRNA Cooperation in Science and Technology (COST) Action is a European-wide consortium established in 2018 with 31 European country members and four associate member countries to build bridges between translational researchers from academia and industry who conduct research on non-coding RNAs, cardiovascular diseases and similar research areas. EU-CardioRNA comprises four core working groups (WG1-4). In the first year since its launch, EU-CardioRNA met biannually to exchange and discuss recent findings in related fields of scientific research, with scientific sessions broadly divided up according to WG. These meetings are also an opportunity to establish interdisciplinary discussion groups, brainstorm ideas and make plans to apply for joint research grants and conduct other scientific activities, including knowledge transfer. Following its launch in Brussels in 2018, three WG meetings have taken place. The first of these in Lisbon, Portugal, the second in Istanbul, Turkey, and the most recent in Maastricht, The Netherlands. Each meeting includes a scientific session from each WG. This meeting report briefly describes the highlights and key take-home messages from each WG session in this first successful year of the EU-CardioRNA COST Action.",
publisher = "MDPI AG",
journal = "Non-coding RNA",
title = "A year in the life of the EU-CardioRNA COST action: CA17129 catalysing transcriptomics research in cardiovascular disease",
volume = "6",
number = "2",
doi = "10.3390/NCRNA6020017"
}

Robinson, E. L., da Costa Gomes, C. P., Potočnjak, I., Hellemans, J., Betsou, F., de Gonzalo-Calvo, D., Stoll, M., Yilmaz, M.B., Ágg, B., Beis, D., Carmo-Fonseca, M., Enguita, F.J., Dogan, S., Tuna, B.G., Schroen, B., Ammerlaan, W., Kuster, G.M., Carpusca, I., Pedrazzini, T., Emanueli, C., Martelli, F., Devaux, Y., Acharya, S., Aghagolzadeh, P., Albinsson, S., Allaer, D., Andova, A., Angione, C., Arnal, J.-F., Arslan, S., Lustrek, M., Maegdefessel, L., Marchese, M., Martino, F., Mazzanti, C., Meli, A., Tonczar, J.M., Murri, M., Niculescu, L.S., Backs, J., Nielsen, N., Nossent, A.Y., Novella, S., Novokmet, N., O'brien, T., Oliveira, C., Orbe, J., Paes, A., Papaneophytou, C., Badimon, L., Perez-Pomares, J., Pinet, F., Popescu, O., Potocnjak, I., Rizanov, A., Ruberto, F., Pipaon, G.S., Sahoo, S., Baker, A., Somoza, A.S., Sanchez-Madrid, F., Sasson, S., Scholz, M., Semenovykh, D., Simionescu, M., Soar, A., Sopić, M., Sorensen, A., Barbalata, T., Spinetti, G., Squire, I., Srivastava, P., Stancu, C.S., Benic, M.S., Stefanizzi, F.M., Steffens, S., Stellos, K., Thum, T., Barbosa, P., Tikhomirov, R., Toledo, M., Trbusic, M., Chalot, S., Turkieh, A., Van Der Bent, M.L., Ingen, E.V., Rooij, E.V., Vanhaverbeke, M., Varga, Z., Bartekova, M., Verjans, R., Vilahur, G., Vinciguerra, M., Vindis, C., Wac, K., Whittaker, A., Xuereb, A., Zangi, L., Zhang, L., Bashiardes, E., Stathopoulos, C., Ciccarelli, M., Serobian, A., Gevorgyan, S., Bencsik, P., Wettinger, S.B., Brandenburger, T., Brittan, M., Bugarski, B., Demur, A.B., Catapano, F., Charchar, F., Charrier, H., Chimenti, S., Chouvardas, P., Closa, D., Colotte, M., Condorelli, G., Curado, J., Dafou, D., Dalgaard, L.T., Calvo, D.G., Windt, L.D., Degoricija, V., Dellago, H., Dieterich, C., Djordjevic, V., Dlaka, A., Doehner, W., Farrugia, R., Fazmin, I., Felekkis, K., Ferdinandylino Ferreira, P., Fiedorowicz, K., Foo, R., Formosa, M., Forte, G., Gaetano, C., Garcia Bermejo, M.L., Garcia-Sosa, A., Gonzalez-Navarro, H., Greco, S., Gulyas-Onodi, Z., Gyongyosi, M., Hackl, M., Hein, L., Heineke, J., Heymans, S., Hlavackova, M., Hoydal, M.A., Jankovic, A., Jeevaratnam, K., Johnson, R., Jusic, A., Justo Da Silva, G., Kalocayova, B., Hadziabdic, K.K., Kardassis, D., Kastner, N., Keravnou, A., Kerkela, R., Kofanova, O., Korac, A., Kura, B., Kuster, G., Lacampagne, A., Lakkisto, P., Robbio, L.L., Lazou, A., Leszek, P., Li, Z., Liapi, E., Lino, M., Luis, R., Gehmlich, K., Dedoussis, G., Makimoto, H., da Costa Martins, P., Sanchez, G., Firat, H., Katare, R., Edling, C., Pesce, M., Capogrossi, M.C.,& Beltrami, A.P.. (2020). A year in the life of the EU-CardioRNA COST action: CA17129 catalysing transcriptomics research in cardiovascular disease. in Non-coding RNA
MDPI AG., 6(2).
https://doi.org/10.3390/NCRNA6020017

Robinson EL, da Costa Gomes CP, Potočnjak I, Hellemans J, Betsou F, de Gonzalo-Calvo D, Stoll M, Yilmaz M, Ágg B, Beis D, Carmo-Fonseca M, Enguita F, Dogan S, Tuna B, Schroen B, Ammerlaan W, Kuster G, Carpusca I, Pedrazzini T, Emanueli C, Martelli F, Devaux Y, Acharya S, Aghagolzadeh P, Albinsson S, Allaer D, Andova A, Angione C, Arnal J, Arslan S, Lustrek M, Maegdefessel L, Marchese M, Martino F, Mazzanti C, Meli A, Tonczar J, Murri M, Niculescu L, Backs J, Nielsen N, Nossent A, Novella S, Novokmet N, O'brien T, Oliveira C, Orbe J, Paes A, Papaneophytou C, Badimon L, Perez-Pomares J, Pinet F, Popescu O, Potocnjak I, Rizanov A, Ruberto F, Pipaon G, Sahoo S, Baker A, Somoza A, Sanchez-Madrid F, Sasson S, Scholz M, Semenovykh D, Simionescu M, Soar A, Sopić M, Sorensen A, Barbalata T, Spinetti G, Squire I, Srivastava P, Stancu C, Benic M, Stefanizzi F, Steffens S, Stellos K, Thum T, Barbosa P, Tikhomirov R, Toledo M, Trbusic M, Chalot S, Turkieh A, Van Der Bent M, Ingen E, Rooij E, Vanhaverbeke M, Varga Z, Bartekova M, Verjans R, Vilahur G, Vinciguerra M, Vindis C, Wac K, Whittaker A, Xuereb A, Zangi L, Zhang L, Bashiardes E, Stathopoulos C, Ciccarelli M, Serobian A, Gevorgyan S, Bencsik P, Wettinger S, Brandenburger T, Brittan M, Bugarski B, Demur A, Catapano F, Charchar F, Charrier H, Chimenti S, Chouvardas P, Closa D, Colotte M, Condorelli G, Curado J, Dafou D, Dalgaard L, Calvo D, Windt L, Degoricija V, Dellago H, Dieterich C, Djordjevic V, Dlaka A, Doehner W, Farrugia R, Fazmin I, Felekkis K, Ferdinandylino Ferreira P, Fiedorowicz K, Foo R, Formosa M, Forte G, Gaetano C, Garcia Bermejo M, Garcia-Sosa A, Gonzalez-Navarro H, Greco S, Gulyas-Onodi Z, Gyongyosi M, Hackl M, Hein L, Heineke J, Heymans S, Hlavackova M, Hoydal M, Jankovic A, Jeevaratnam K, Johnson R, Jusic A, Justo Da Silva G, Kalocayova B, Hadziabdic K, Kardassis D, Kastner N, Keravnou A, Kerkela R, Kofanova O, Korac A, Kura B, Kuster G, Lacampagne A, Lakkisto P, Robbio L, Lazou A, Leszek P, Li Z, Liapi E, Lino M, Luis R, Gehmlich K, Dedoussis G, Makimoto H, da Costa Martins P, Sanchez G, Firat H, Katare R, Edling C, Pesce M, Capogrossi M, Beltrami A. A year in the life of the EU-CardioRNA COST action: CA17129 catalysing transcriptomics research in cardiovascular disease. in Non-coding RNA. 2020;6(2).
doi:10.3390/NCRNA6020017 .

Robinson, Emma Louise, da Costa Gomes, Clarissa Pedrosa, Potočnjak, Ines, Hellemans, Jan, Betsou, Fay, de Gonzalo-Calvo, D., Stoll, M., Yilmaz, M.B., Ágg, B., Beis, D., Carmo-Fonseca, M., Enguita, F.J., Dogan, S., Tuna, B.G., Schroen, B., Ammerlaan, W., Kuster, G.M., Carpusca, I., Pedrazzini, T., Emanueli, C., Martelli, F., Devaux, Y., Acharya, S., Aghagolzadeh, P., Albinsson, S., Allaer, D., Andova, A., Angione, C., Arnal, J.-F., Arslan, S., Lustrek, M., Maegdefessel, L., Marchese, M., Martino, F., Mazzanti, C., Meli, A., Tonczar, J.M., Murri, M., Niculescu, L.S., Backs, J., Nielsen, N., Nossent, A.Y., Novella, S., Novokmet, N., O'brien, T., Oliveira, C., Orbe, J., Paes, A., Papaneophytou, C., Badimon, L., Perez-Pomares, J., Pinet, F., Popescu, O., Potocnjak, I., Rizanov, A., Ruberto, F., Pipaon, G.S., Sahoo, S., Baker, A., Somoza, A.S., Sanchez-Madrid, F., Sasson, S., Scholz, M., Semenovykh, D., Simionescu, M., Soar, A., Sopić, Miron, Sorensen, A., Barbalata, T., Spinetti, G., Squire, I., Srivastava, P., Stancu, C.S., Benic, M.S., Stefanizzi, F.M., Steffens, S., Stellos, K., Thum, T., Barbosa, P., Tikhomirov, R., Toledo, M., Trbusic, M., Chalot, S., Turkieh, A., Van Der Bent, M.L., Ingen, E.V., Rooij, E.V., Vanhaverbeke, M., Varga, Z., Bartekova, M., Verjans, R., Vilahur, G., Vinciguerra, M., Vindis, C., Wac, K., Whittaker, A., Xuereb, A., Zangi, L., Zhang, L., Bashiardes, E., Stathopoulos, C., Ciccarelli, M., Serobian, A., Gevorgyan, S., Bencsik, P., Wettinger, S.B., Brandenburger, T., Brittan, M., Bugarski, B., Demur, A.B., Catapano, F., Charchar, F., Charrier, H., Chimenti, S., Chouvardas, P., Closa, D., Colotte, M., Condorelli, G., Curado, J., Dafou, D., Dalgaard, L.T., Calvo, D.G., Windt, L.D., Degoricija, V., Dellago, H., Dieterich, C., Djordjevic, V., Dlaka, A., Doehner, W., Farrugia, R., Fazmin, I., Felekkis, K., Ferdinandylino Ferreira, P., Fiedorowicz, K., Foo, R., Formosa, M., Forte, G., Gaetano, C., Garcia Bermejo, M.L., Garcia-Sosa, A., Gonzalez-Navarro, H., Greco, S., Gulyas-Onodi, Z., Gyongyosi, M., Hackl, M., Hein, L., Heineke, J., Heymans, S., Hlavackova, M., Hoydal, M.A., Jankovic, A., Jeevaratnam, K., Johnson, R., Jusic, A., Justo Da Silva, G., Kalocayova, B., Hadziabdic, K.K., Kardassis, D., Kastner, N., Keravnou, A., Kerkela, R., Kofanova, O., Korac, A., Kura, B., Kuster, G., Lacampagne, A., Lakkisto, P., Robbio, L.L., Lazou, A., Leszek, P., Li, Z., Liapi, E., Lino, M., Luis, R., Gehmlich, K., Dedoussis, G., Makimoto, H., da Costa Martins, P., Sanchez, G., Firat, H., Katare, R., Edling, C., Pesce, M., Capogrossi, M.C., Beltrami, A.P., "A year in the life of the EU-CardioRNA COST action: CA17129 catalysing transcriptomics research in cardiovascular disease" in Non-coding RNA, 6, no. 2 (2020),
https://doi.org/10.3390/NCRNA6020017 . .